PRESS RELEASE
News
-
-
-
-
-
PRESS RELEASE
A new milestone towards the market launch of AXPERA: EU Member States unanimously vote in favour of the approval of Amoéba's biocontrol active substance
Amoéba receives unanimous approval from EU Member States for low-risk biocontrol substance based on amoebae lysate, a milestone for AXPERA solution market launch in Europe from 2026 -
-
PRESS RELEASE
Amoéba announces the nomination of Charlotte Franceries, a leading figure in the cosmetics and communications industry, to its Board of Directors
Amoéba announces the proposed appointment of Charlotte Franceries as a member of its Board of Directors, bringing extensive expertise from the cosmetics industry -
-
PRESS RELEASE
Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.
Amoéba to continue preparing for commercial launch of biocontrol solution AXPERA with Koppert, following successful authorisations. Company aims to meet market expectations for innovative biocontrol solutions -
